Announcements Trials
Browse Landscape

Phase

Phase NA 10Phase 2 7Phase 1 6Phase 1/2 3Phase EARLY_PHASE1 2Phase 4 2Phase 3 2Phase 2/3 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 2

Conditions

Breast Neoplasms 1128Carcinoma, Non-Small-Cell Lung 718Neoplasms 545Prostatic Neoplasms 502Colorectal Neoplasms 438Multiple Myeloma 336Lung Neoplasms 309Neoplasm Metastasis 288Leukemia, Myeloid, Acute 263Stomach Neoplasms 248Carcinoma, Hepatocellular 245Ovarian Neoplasms 225Rectal Neoplasms 211Colonic Neoplasms 204Lymphoma, Follicular 200Lymphoma 199Leukemia 190Uterine Cervical Neoplasms 181Head and Neck Neoplasms 174Pancreatic Neoplasms 171Lymphoma, Non-Hodgkin 167Leukemia, Lymphocytic, Chronic, B-Cell 166Lymphoma, Large B-Cell, Diffuse 163Recurrence 161Melanoma 158Precursor Cell Lymphoblastic Leukemia-Lymphoma 154Squamous Cell Carcinoma of Head and Neck 147Pain 141Urinary Bladder Neoplasms 139Brain Neoplasms 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Interventional × Adrenal Gland Neoplasms × Clear all
NCT02010957 2025-06-10

FAMIAN

Wuerzburg University Hospital

Phase 3 Terminated
85 enrolled
Endocrine

Adrenal Gland Neoplasms

NCT00037843 2012-02-22

Iodine I-131 Iodocholesterol, Its Use in Adrenal Screening

M.D. Anderson Cancer Center

Phase 3 Completed
114 enrolled
Endocrine

Adrenal Gland Diseases, Adrenal Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡